C
CENTURION İlaç Sanayi ve Ticaret A.Ş.
Biopharmaceutical Products for Chronic and Rare Diseases
- Founded
- Founded 1949
- Locations
- 1 location
C
CENTURION İlaç Sanayi ve Ticaret A.Ş.
Biopharmaceutical Products for Chronic and Rare Diseases
- Founded
- Founded 1949
- Locations
- 1 location
About
Centurion Pharma is a privately-owned Turkish biopharmaceutical company specialized in blood products, vaccines, biosimilars, and specialty hospital generics. Operating a state-of-the-art sterile injectable manufacturing facility with EU GMP certification in Ankara, the company collaborates with world-leading partners to develop and launch high-quality, cost-effective therapeutic options for patients globally.
Services
2Sterile Injectable Manufacturing Services
Centurion operates an EU GMP-certified manufacturing facility equipped with advanced sterile injectable systems. Offering contract development and high-capacity manufacturing of liquid and lyophilized vials, pre-filled syringes, and cartridges to deliver reliable healthcare products under strict international quality standards.
Pharmaceutical Research and Development Services
Our R&D Center leverages scientifically qualified personnel and advanced analytical and biotechnological laboratories to develop complex generics and biosimilars. We provide complete R&D solutions including formulation trials, analytical validation, and clinical assessments.
Products
4AAC
Abhayrab
Abhayrab is an active rabies vaccine manufactured to deliver protective antibody responses for individuals exposed to the rabies virus. The product helps healthcare professionals manage infection risks through safe, high-quality vaccine immunization protocols.
Albuman
Albuman is a sterile, high-quality solution of human albumin developed to restore and maintain circulating blood volume and treat protein deficiency in patients suffering from severe volume loss or advanced liver disease.
Cofact
Cofact is a concentrated prothrombin complex formulated to treat active bleeding and hemorrhage caused by deficiency in vitamin K-dependent clotting factors, specifically including factors II, VII, IX, and X.
Quick Info
- Followers
- …
- Founded
- 1949
- Operating in
- BrazilJordanTurkeyUkraineYemen
- Company type
- Tech Company
- Website
Industries2
Solution Areas3
Sub Industries3
Audience
Target Industries
Not specified yet
Customer Segments
Not specified yet
Business Model
Locations1
HeadquarterHQ
Maslak Mah. Eski Buyukdere Cad. No:1 İç Kapı No:16 Sarıyer, İstanbul, Turkey
References2
- 1.Accord
- 2.Elpen Pharmaceutical Co. Inc.
Target Customer Brands
No target brands listed yet.
Recent activity
2Sep 2026
1949
Tags3
#biotechnology
#healthcare
#biosimilars

